We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


International Stem Cell Presents Several Research Advances at Cell Science 2011 in Philadelphia

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "International Stem Cell Presents Several Research Advances at Cell Science 2011 in Philadelphia"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Vice president, Dr. Ruslan Semechkin, opened the conference, discussing the latest trends in the use of stem cells to treat various diseases of the central nervous system, while the company's director of translational research, Dr. Alina Ostrowska, led a follow-on presentation regarding International Stem Cell's new method of obtaining functioning neuron cells from human parthenogenetic stem cells (hpSCs).

Dr. Semechkin commented: "I'm honored to be opening this conference and to be debating the latest advances in stem cell therapies.

"ISCO will also be presenting the most recent results from two of our most important research programs, where we continue to further characterize our parthenogenetic stem cell lines and their ability to form functioning liver-like cell and functioning neuron-like cells."

Last month, the company released the results of the first series of animal trials of neuronal cells derived from hpSCs.

The company said the cells were able to survive in the brains of mice without producing a tumour, representing a key milestone towards possible therapeutic applications of hpSCs, including the treatment of Parkinson's disease.

The company's parthenogenetic stem cell technology can be used to derive pluripotent stem cells, meaning they can be transformed into any cell type in the body. The parthenogenetic stem cells are derived from unfertilized eggs, avoiding the ethical issues behind the destruction of viable human embryos.

These cells have also demonstrated they are better in terms of the immune system, as one single stem cell line can be genetically matched to millions of people, reducing the need for immuno-suppressants.